TXA for GI Bleeds? The HALT-IT Trial

July 15, 2020 00:26:28
TXA for GI Bleeds?  The HALT-IT Trial
Critical Care Perspectives in Emergency Medicine
TXA for GI Bleeds? The HALT-IT Trial

Jul 15 2020 | 00:26:28

/

Show Notes

The use of tranexamic acid (TXA) has markedly increased since the results of the CRASH-II trial were published.  In addition to its use in trauma, TXA has been evaluated and used in numerous other conditions, including post-partum hemorrhage and epistaxis.  Recently, the HALT-IT Trial was published online in the Lancet, which evaluated the use of TXA in patients with acute gastrointestinal bleeding.  In this podcast we discuss the HALT-IT Trial and its implications for clinical practice. 

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

February 01, 2022 00:20:19
Episode Cover

EM-STAT!

Resuscitating the sick patient and providing ongoing critical care is incredibly challenging in critical access locations and resource limited EDs.  In this podcast, we...

Listen

Episode

December 05, 2024 00:25:46
Episode Cover

High-Intensity NIPPV for Acute COPD Exacerbations?

NIPPV is frequently used in the management of critically ill patients presenting with an acute COPD exacerbation, as NIPPV decreases the rates of intubation...

Listen

Episode 0

December 11, 2020 00:35:50
Episode Cover

2020 AHA Updates: Post-Arrest Care

The period following ROSC from cardiac arrest is a time when lives can be saved…or lost.  A systematic and comprehensive approach to post-arrest care...

Listen